Literature DB >> 17300487

A daring treatment and a successful outcome: the need for targeted therapies for pediatric respiratory viruses.

Patricia DeLaMora, Anne Moscona.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17300487     DOI: 10.1111/j.1399-3046.2006.00654.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


× No keyword cloud information.
  4 in total

1.  A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo.

Authors:  Anne Moscona; Matteo Porotto; Samantha Palmer; Caroline Tai; Lori Aschenbrenner; Gallen Triana-Baltzer; Qi-Xiang Li; David Wurtman; Stefan Niewiesk; Fang Fang
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

2.  Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection.

Authors:  Samantha G Palmer; Ilaria DeVito; Stephen G Jenkins; Stefan Niewiesk; Matteo Porotto; Anne Moscona
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

3.  Features of Circulating Parainfluenza Virus Required for Growth in Human Airway.

Authors:  Laura M Palermo; Manik Uppal; Lucy Skrabanek; Paul Zumbo; Soren Germer; Nora C Toussaint; Bert K Rima; Devra Huey; Stefan Niewiesk; Matteo Porotto; Anne Moscona
Journal:  MBio       Date:  2016-03-15       Impact factor: 7.867

4.  Hijacking the Fusion Complex of Human Parainfluenza Virus as an Antiviral Strategy.

Authors:  T C Marcink; E Yariv; K Rybkina; V Más; F T Bovier; A des Georges; A L Greninger; C A Alabi; M Porotto; N Ben-Tal; A Moscona
Journal:  mBio       Date:  2020-02-11       Impact factor: 7.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.